WuXi Biologics (Cayman) Inc.
2269Biotechnology
HK$45.06−2.72%As of Oct 29vs prior close
- Market cap
- $23.6B
- P/E (TTM)
- 31.4×
- P/E (FY1)
- 24.8×
- From 52W high
- −22.18%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥23.6B
- Net margin
- 21.20%
Nomior Score
66
Ascendant MoverTop 15% of the scored universe
Growth66
Quality63
Value45
Momentum80
Resilience45
Growth
+12.59%revenue a year over 3 fiscal years
YE22 CN¥15.3BLTM CN¥23.6B
Connections
Revenue to profitYE25
23% of revenue became net profit, up 5 pts on a year.